Research.Patient.info
Allergic rhinoconjunctivitis research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic use (Phase IV)
International multicentre, open-label, phase IV clinical trial to evaluate the efficacy, safety and effect on quality of life of bilastine in children with allergic rhinoconjunctivitis
This study looks at how well an allergy medicine called bilastine works in children with allergic rhinoconjunctivitis (itchy, watery eyes and runny noses caused by allergies). Researchers want to see if this melt-in-the-mouth tablet improves symptoms and daily life over two weeks of treatment.
Poland · Spain · Italy - recruitingTherapeutic confirmatory (Phase III)
Multicenter, double-blind, randomized, placebo-controlled phase III clinical trial in parallel groups which evaluates the clinical efficacy and safety of immunotherapy with the purified major allergen Cup a 1, in patients with moderate/severe allergic rhino conjunctivitis with or without controlled asthma, sensitized to Cupressaceae
This study is testing a new treatment for people with moderate to severe hay fever caused by cypress tree pollen. It aims to see if a special type of immunotherapy, using a purified allergen called Cup a 1, can reduce symptoms and improve quality of life.
Spain